Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
IL-36 in psoriasis.
Towne JE, Sims JE. Towne JE, et al. Among authors: sims je. Curr Opin Pharmacol. 2012 Aug;12(4):486-90. doi: 10.1016/j.coph.2012.02.009. Epub 2012 Mar 5. Curr Opin Pharmacol. 2012. PMID: 22398321 Review.
A single amino acid difference between human and monkey interleukin (IL)-1beta dictates effective binding to soluble type II IL-1 receptor.
Smith DE, Ketchem RR, Moore H, Anderson Z, Renshaw BR, Friend DJ, Sims JE. Smith DE, et al. Among authors: sims je. J Biol Chem. 2002 Dec 6;277(49):47619-25. doi: 10.1074/jbc.M206636200. Epub 2002 Sep 28. J Biol Chem. 2002. PMID: 12356774
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.
Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE. Towne JE, et al. Among authors: sims je. J Biol Chem. 2004 Apr 2;279(14):13677-88. doi: 10.1074/jbc.M400117200. Epub 2004 Jan 20. J Biol Chem. 2004. PMID: 14734551
Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type II and interleukin-1 receptor accessory protein.
Sims JE, Smith DE. Sims JE, et al. Eur Cytokine Netw. 2003 Apr-Jun;14(2):77-81. Eur Cytokine Netw. 2003. PMID: 12957787 Review. No abstract available.
The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action.
Smith DE, Hanna R, Della Friend, Moore H, Chen H, Farese AM, MacVittie TJ, Virca GD, Sims JE. Smith DE, et al. Among authors: sims je. Immunity. 2003 Jan;18(1):87-96. doi: 10.1016/s1074-7613(02)00514-9. Immunity. 2003. PMID: 12530978
IL-1 and IL-18 receptors, and their extended family.
Sims JE. Sims JE. Curr Opin Immunol. 2002 Feb;14(1):117-22. doi: 10.1016/s0952-7915(01)00306-5. Curr Opin Immunol. 2002. PMID: 11790541 Review.
IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.
Blumberg H, Dinh H, Dean C Jr, Trueblood ES, Bailey K, Shows D, Bhagavathula N, Aslam MN, Varani J, Towne JE, Sims JE. Blumberg H, et al. Among authors: sims je. J Immunol. 2010 Oct 1;185(7):4354-62. doi: 10.4049/jimmunol.1000313. Epub 2010 Sep 10. J Immunol. 2010. PMID: 20833839
Externalization of the leaderless cytokine IL-1F6 occurs in response to lipopolysaccharide/ATP activation of transduced bone marrow macrophages.
Martin U, Scholler J, Gurgel J, Renshaw B, Sims JE, Gabel CA. Martin U, et al. Among authors: sims je. J Immunol. 2009 Sep 15;183(6):4021-30. doi: 10.4049/jimmunol.0803301. Epub 2009 Aug 28. J Immunol. 2009. PMID: 19717513
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.
Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, Kanaly ST, Towne JE, Willis CR, Kuechle MK, Sims JE, Peschon JJ. Blumberg H, et al. Among authors: sims je. J Exp Med. 2007 Oct 29;204(11):2603-14. doi: 10.1084/jem.20070157. Epub 2007 Oct 1. J Exp Med. 2007. PMID: 17908936 Free PMC article.
A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1.
Smith DE, Lipsky BP, Russell C, Ketchem RR, Kirchner J, Hensley K, Huang Y, Friedman WJ, Boissonneault V, Plante MM, Rivest S, Sims JE. Smith DE, et al. Among authors: sims je. Immunity. 2009 Jun 19;30(6):817-31. doi: 10.1016/j.immuni.2009.03.020. Epub 2009 May 28. Immunity. 2009. PMID: 19481478 Free PMC article.
103 results
Jump to page